IDEAYA Biosciences, Inc. (IDYA) vs Arcus Biosciences, Inc. (RCUS)
IDEAYA Biosciences, Inc. and Arcus Biosciences, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. is the larger, with a market value of $3.6B against $3.2B — 1.1× the size. IDEAYA Biosciences, Inc. grew revenue faster over the last twelve months: 901.2% against −55.3%. IDEAYA Biosciences, Inc. has the higher net margin (−74.8% vs −393.2%) and the lower return on invested capital (−36.7% vs 0.00%). Across the 17 metrics below, IDEAYA Biosciences, Inc. leads on 15 and Arcus Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | IDYA | RCUS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (92.66%) | (415.38%) | 0.00% |
| Net margin | (74.75%) | (393.16%) | 0.00% |
| Free cash flow margin | (48.64%) | (405.13%) | 0.00% |
| Return on equity | (16.22%) | (90.82%) | (57.72%) |
| Return on assets | (14.89%) | (46.02%) | (49.22%) |
| Return on invested capital | (36.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack